| Ticker |
Owner |
Relationship |
Date |
Transaction |
Cost  |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| MDGL | Levy Richard S | Director | Apr 01 | Option Exercise | 63.92 | 11,000 | 703,160 | 21,298 | Apr 03 08:47 PM |
| MDGL | Levy Richard S | Director | Apr 01 | Sale | 257.48 | 11,000 | 2,832,335 | 10,298 | Apr 03 08:47 PM |
| MDGL | Levy Richard S | Director | Jan 17 | Option Exercise | 103.02 | 22,489 | 2,316,844 | 31,589 | Jan 19 07:57 PM |
| MDGL | Levy Richard S | Director | Jan 17 | Sale | 293.15 | 22,489 | 6,592,686 | 9,100 | Jan 19 07:57 PM |
| KOD | Levy Richard S | Director | Mar 20 | Buy | 44.33 | 1,000 | 44,330 | 1,000 | Mar 24 04:50 PM |
|
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jan 06 | Option Exercise | 18.32 | 3,937 | 72,126 | 20,863 | Jan 08 04:37 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jan 06 | Sale | 101.86 | 3,937 | 401,023 | 16,926 | Jan 08 04:37 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Dec 07 | Option Exercise | 18.32 | 3,937 | 72,126 | 20,863 | Dec 09 04:31 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Dec 07 | Sale | 106.18 | 3,937 | 418,031 | 16,926 | Dec 09 04:31 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Nov 06 | Option Exercise | 18.32 | 3,936 | 72,108 | 20,862 | Nov 10 08:21 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Nov 06 | Sale | 116.51 | 3,936 | 458,583 | 16,926 | Nov 10 08:21 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Oct 06 | Option Exercise | 18.32 | 3,937 | 72,126 | 20,863 | Oct 08 04:28 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Oct 06 | Sale | 122.29 | 3,937 | 481,456 | 16,926 | Oct 08 04:28 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Sep 11 | Sale | 130.00 | 4,301 | 559,130 | 16,926 | Sep 15 04:31 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Sep 08 | Option Exercise | 18.32 | 3,937 | 72,126 | 25,164 | Sep 10 04:44 PM |
|
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Sep 08 | Sale | 118.90 | 3,937 | 468,109 | 21,227 | Sep 10 04:44 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Aug 06 | Option Exercise | 18.32 | 3,936 | 72,108 | 25,163 | Aug 10 04:29 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Aug 06 | Sale | 111.95 | 3,936 | 440,635 | 21,227 | Aug 10 04:29 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jul 15 | Option Exercise | 17.79 | 70,217 | 1,249,160 | 91,444 | Jul 16 04:36 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jul 15 | Sale | 120.00 | 70,217 | 8,426,040 | 21,227 | Jul 16 04:36 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jul 06 | Option Exercise | 18.32 | 3,937 | 72,126 | 25,164 | Jul 08 04:52 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jul 06 | Sale | 107.00 | 3,937 | 421,259 | 21,227 | Jul 08 04:52 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jun 19 | Option Exercise | 17.79 | 20,000 | 355,800 | 41,227 | Jun 23 04:28 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jun 19 | Sale | 108.13 | 20,000 | 2,162,600 | 21,227 | Jun 23 04:28 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jun 08 | Option Exercise | 18.32 | 3,937 | 72,126 | 25,164 | Jun 10 04:43 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Jun 08 | Sale | 107.58 | 3,937 | 423,542 | 21,227 | Jun 10 04:43 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | May 06 | Option Exercise | 18.32 | 7,412 | 135,788 | 28,639 | May 08 04:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | May 06 | Sale | 99.43 | 7,412 | 736,975 | 21,227 | May 08 04:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Apr 06 | Option Exercise | 18.32 | 25,000 | 458,000 | 46,227 | Apr 08 04:17 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Apr 06 | Sale | 88.77 | 25,000 | 2,219,250 | 21,227 | Apr 08 04:17 PM |
|
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Mar 06 | Option Exercise | 18.32 | 25,000 | 458,000 | 46,227 | Mar 10 05:13 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev Officer | Mar 06 | Sale | 89.91 | 25,000 | 2,247,750 | 21,227 | Mar 10 05:13 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 17 | Option Exercise | 15.66 | 12,000 | 187,947 | 30,205 | Feb 18 05:49 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 17 | Sale | 76.90 | 12,000 | 922,800 | 18,205 | Feb 18 05:49 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 06 | Option Exercise | 18.32 | 25,000 | 458,000 | 43,205 | Feb 10 04:33 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 06 | Sale | 75.11 | 25,000 | 1,877,750 | 18,205 | Feb 10 04:33 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 16 | Option Exercise | 14.72 | 12,000 | 176,640 | 30,205 | Jan 20 05:27 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 16 | Sale | 73.07 | 12,000 | 876,840 | 18,205 | Jan 20 05:27 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 06 | Option Exercise | 18.32 | 25,000 | 458,000 | 43,205 | Jan 08 05:34 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 06 | Sale | 71.84 | 25,000 | 1,796,000 | 18,205 | Jan 08 05:34 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Dec 16 | Option Exercise | 14.72 | 12,000 | 176,640 | 30,205 | Dec 18 04:17 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Dec 16 | Sale | 72.36 | 12,000 | 868,320 | 18,205 | Dec 18 04:17 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Nov 17 | Option Exercise | 14.72 | 12,000 | 176,640 | 30,205 | Nov 19 04:49 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Nov 17 | Sale | 69.97 | 12,000 | 839,640 | 18,205 | Nov 19 04:49 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Oct 23 | Option Exercise | 3.11 | 13,904 | 43,241 | 18,205 | Oct 24 04:13 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Oct 16 | Option Exercise | 14.72 | 8,000 | 117,760 | 12,301 | Oct 20 04:10 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Oct 16 | Sale | 49.03 | 8,000 | 392,240 | 4,301 | Oct 20 04:10 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Sep 16 | Option Exercise | 14.72 | 8,000 | 117,760 | 12,301 | Sep 18 04:11 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Sep 16 | Sale | 47.58 | 8,000 | 380,640 | 4,301 | Sep 18 04:11 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jul 16 | Option Exercise | 14.72 | 8,000 | 117,760 | 12,301 | Jul 18 05:11 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jul 16 | Sale | 48.15 | 8,000 | 385,200 | 4,301 | Jul 18 05:11 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jun 16 | Option Exercise | 14.72 | 8,000 | 117,760 | 12,301 | Jun 18 04:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jun 16 | Sale | 53.88 | 8,000 | 431,040 | 4,301 | Jun 18 04:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | May 16 | Option Exercise | 14.72 | 8,000 | 117,760 | 12,301 | May 20 04:09 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | May 16 | Sale | 50.68 | 8,000 | 405,440 | 4,301 | May 20 04:09 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 13 | Option Exercise | 8.34 | 191,309 | 1,595,213 | 195,610 | Feb 18 06:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 14 | Option Exercise | 10.89 | 39,787 | 433,346 | 44,088 | Feb 18 06:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 14 | Sale | 66.13 | 39,787 | 2,631,114 | 4,301 | Feb 18 06:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 13 | Sale | 66.38 | 191,309 | 12,699,091 | 4,301 | Feb 18 06:02 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Sep 06 | Option Exercise | 11.98 | 25,000 | 299,500 | 25,000 | Sep 09 04:13 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Sep 06 | Sale | 35.28 | 25,000 | 882,000 | 0 | Sep 09 04:13 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | May 13 | Option Exercise | 7.09 | 60,000 | 425,400 | 60,000 | May 15 04:17 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | May 13 | Sale | 22.30 | 55,699 | 1,242,088 | 4,301 | May 15 04:17 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 15 | Option Exercise | 6.84 | 98,440 | 673,176 | 98,440 | Feb 20 04:33 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Feb 15 | Sale | 22.48 | 98,440 | 2,212,931 | 0 | Feb 20 04:33 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Apr 27 | Option Exercise | 8.76 | 30,000 | 262,948 | 30,000 | May 01 05:09 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Apr 27 | Sale | 22.95 | 30,000 | 688,500 | 0 | May 01 05:09 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 18 | Option Exercise | 6.70 | 40,310 | 270,139 | 40,310 | Jan 20 04:16 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Jan 18 | Sale | 15.80 | 40,310 | 636,847 | 0 | Jan 20 04:16 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Mar 15 | Option Exercise | 4.19 | 20,000 | 83,800 | 20,000 | Mar 17 04:41 PM |
| INCY | Levy Richard S | EVP, Chief Drug Dev&Medical Of | Mar 15 | Sale | 12.94 | 20,000 | 258,800 | 0 | Mar 17 04:41 PM |
